Navigation Links
Tobacco Companies Admit Their Products Cause Cancer but Not in Those Who Sue Them

Despite publicly admitting, to varying degrees, that cigarette smoking causes cancer, the industry has consistently dismissed these claims for people who have// sued them, reveals an analysis of recent lawsuits, published in a supplement to Tobacco Control.

The authors looked at the opening and closing statements of the defence, witness statements, and depositions for 34 personal injury claims brought against major tobacco manufacturers between 1986 and 2003 in the US.

They used data archived in the Tobacco Deposition and Trial Testimony Archive (DATTA).

Each of the arguments put forward by the companies were categorised into seven different groups.

These included an absence of scientific proof that cigarette smoking causes cancer, denials that the plaintiff had lung cancer, or accepting that the plaintiff had lung cancer, but of a variety not caused by the particular product in question.

The defence also argued that the presence of other risk factors invalidated the claims that tobacco was solely responsible and that the plaintiff had exercised free will, despite knowing the risks to health of smoking.

The use of the 'no scientific proof to link cigarette smoking with cancer' defence declined as companies began to publicly admit that smoking causes disease, starting in the late 1990s.

But the defence of mitigating factors and the exercise of free will correspondingly increased over the same period.

The authors conclude: The cigarette companies, through their public admissions and courtroom arguments, seem to be saying: 'Yes, smoking causes lung cancer, but not in the people who sue us.'

Source-Newswise
'"/>




Page: 1

Related medicine news :

1. Tobacco chewing leads to dental caries
2. Tobacco and alcohol connected to larger health problems
3. Vegetables decrease Tobacco Toxins
4. Exposure To Tobacco Smoke Can Lead To Sickle Cell Crisis
5. Tobacco Found To Trigger Familial Pancreatic Cancer
6. Tobacco smoke increases the levels of Cox 2.
7. Aggressive Tobacco taxation policy can reduce cigarette smoking
8. Role Of Tobacco In Development Of Oral Cancer And Heart Disease
9. Women More Prone To Risk of Colorectal Cancer from Tobacco
10. WHO Intensifies Anti-Tobacco war
11. New Zealand Researchers Call For Tobacco-Free Society
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: